Literature DB >> 34670862

The Epithelial-Stromal Microenvironment in Early Colonic Neoplasia.

Takayasu Ideta1, Boyang Li2, Christopher Flynn3, Yuichi Igarashi1, Geoffrey Lowman4, Tim Looney4, Thomas J Devers5, John Birk5, Faripour Forouhar6, Charles Giardina2, Daniel W Rosenberg7.   

Abstract

Stromal cells play a central role in promoting the progression of colorectal cancer. Here, we analyze molecular changes within the epithelial and stromal compartments of dysplastic aberrant crypt foci (ACF) formed in the ascending colon, where rapidly developing interval cancers occur. We found strong activation of numerous neutrophil/monocyte chemokines, consistent with localized inflammation. The data also indicated a decrease in interferon signaling and cell-based immunity. The immune checkpoint and T-cell exhaustion gene PDCD1 was one of the most significantly upregulated genes, which was accompanied by a decrease in cytotoxic T-cell effector gene expression. In addition, CDKN2A expression was strongly upregulated in the stroma and downregulated in the epithelium, consistent with diverse changes in senescence-associated signaling on the two tissue compartments. IMPLICATIONS: Decreased CD8 T-cell infiltration within proximal colon ACF occurs within the context of a robust inflammatory response and potential stromal cell senescence, thus providing new insight into potential promotional drivers for tumors in the proximal colon. ©2021 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2021        PMID: 34670862      PMCID: PMC8738147          DOI: 10.1158/1541-7786.MCR-21-0202

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   6.333


  29 in total

Review 1.  Oncogene- and tumor suppressor gene-mediated suppression of cellular senescence.

Authors:  Lars-Gunnar Larsson
Journal:  Semin Cancer Biol       Date:  2011-10-24       Impact factor: 15.707

2.  Up and downregulation of p16(Ink4a) expression in BRAF-mutated polyps/adenomas indicates a senescence barrier in the serrated route to colon cancer.

Authors:  Lydia Kriegl; Jens Neumann; Michael Vieth; Florian R Greten; Simone Reu; Andreas Jung; Thomas Kirchner
Journal:  Mod Pathol       Date:  2011-03-18       Impact factor: 7.842

Review 3.  CCR7 mediates inflammation-associated tumor progression.

Authors:  Yvonne K Mburu; Jun Wang; Michelle A Wood; William H Walker; Robert L Ferris
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

Review 4.  PD-1 and its ligands in tolerance and immunity.

Authors:  Mary E Keir; Manish J Butte; Gordon J Freeman; Arlene H Sharpe
Journal:  Annu Rev Immunol       Date:  2008       Impact factor: 28.527

5.  Mutations in BRAF and KRAS differentially distinguish serrated versus non-serrated hyperplastic aberrant crypt foci in humans.

Authors:  Daniel W Rosenberg; Shi Yang; Devon C Pleau; Emily J Greenspan; Richard G Stevens; Thiruchandurai V Rajan; Christopher D Heinen; Joel Levine; Yijian Zhou; Michael J O'Brien
Journal:  Cancer Res       Date:  2007-04-15       Impact factor: 12.701

Review 6.  CD8 T Cell Exhaustion in Chronic Infection and Cancer: Opportunities for Interventions.

Authors:  Masao Hashimoto; Alice O Kamphorst; Se Jin Im; Haydn T Kissick; Rathi N Pillai; Suresh S Ramalingam; Koichi Araki; Rafi Ahmed
Journal:  Annu Rev Med       Date:  2018-01-29       Impact factor: 13.739

7.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2.

Authors:  Michael I Love; Wolfgang Huber; Simon Anders
Journal:  Genome Biol       Date:  2014       Impact factor: 13.583

8.  CCR7 mediates human breast cancer cell invasion, migration by inducing epithelial-mesenchymal transition and suppressing apoptosis through AKT pathway.

Authors:  Bing Xu; Minjie Zhou; Wencai Qiu; Jueming Ye; Qiming Feng
Journal:  Cancer Med       Date:  2017-04-04       Impact factor: 4.452

9.  B-RAF mutation and accumulated gene methylation in aberrant crypt foci (ACF), sessile serrated adenoma/polyp (SSA/P) and cancer in SSA/P.

Authors:  A Inoue; K Okamoto; Y Fujino; T Nakagawa; N Muguruma; K Sannomiya; Y Mitsui; T Takaoka; S Kitamura; H Miyamoto; T Okahisa; T Fujimori; I Imoto; T Takayama
Journal:  Br J Cancer       Date:  2014-10-14       Impact factor: 7.640

10.  Limiting oxidative DNA damage reduces microbe-induced colitis-associated colorectal cancer.

Authors:  Thergiory Irrazabal; Bhupesh K Thakur; Mingsong Kang; Yann Malaise; Catherine Streutker; Erin O Y Wong; Julia Copeland; Robert Gryfe; David S Guttman; William W Navarre; Alberto Martin
Journal:  Nat Commun       Date:  2020-04-14       Impact factor: 14.919

View more
  1 in total

1.  Comprehensive proteomic signature and identification of CDKN2A as a promising prognostic biomarker and therapeutic target of colorectal cancer.

Authors:  Qian-Qian Wang; Yuan-Chen Zhou; Yu-Jia Zhou Ge; Geng Qin; Teng-Fei Yin; Dong-Yan Zhao; Chang Tan; Shu-Kun Yao
Journal:  World J Clin Cases       Date:  2022-08-06       Impact factor: 1.534

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.